Improved outcomes with leadless vs. single-chamber transvenous pacemaker in haemodialysis patients
Open Access
- 1 October 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (11)
Abstract
Aims: Cardiac conduction disorders are common in haemodialysis patients, with a relatively high rate of pacemaker implantations. Pacemaker-related complications, especially lead infections and central venous stenosis, pose significant challenges in this population. This study aims to compare single-chamber leadless pacemaker to single-chamber transvenous pacemakers in terms of survival and related complications in haemodialysis patients. Methods and results: This retrospective study included adult haemodialysis patients who received a first single-chamber transvenous or leadless pacemaker between January 2017 and December 2020. Data were obtained from the French national REIN registry matched to the national health databases (Système National des Données de Santé). Propensity score matching was used to balance baseline characteristics. Survival and complications were compared between groups by Cox regression and by competitive risk models, respectively. One hundred and seventy-eight patients were included after propensity score matching, with 89 patients in each group. The median follow-up time was 24 (range 7–37) months. Leadless pacemakers were associated with significantly lower all-cause mortality rates compared to transvenous pacemakers [hazard ratio (HR) = 0.68, 95% confidence interval (CI) (0.47–0.99)]. Device-related infections are significantly lower with leadless pacemakers throughout the follow-up period (HR 0.43, 95% CI 0.21–0.86). Leadless pacemaker recipients also required fewer vascular access interventions [odds ratio 0.53, 95% CI (0.33–0.68)] on arteriovenous fistula. Conclusion: With the limitations of its observational design, this study suggests that leadless pacemakers are associated with a lower rate of complications and better survival as compared with transvenous VVI pacemakers in haemodialysis patients, supporting to consider their preferential use in this population.Keywords
Funding Information
- Agence de la Biomédecine
- Agence Régionale de Santé
This publication has 32 references indexed in Scilit:
- Percutaneous Implantation of an Entirely Intracardiac Leadless PacemakerNew England Journal of Medicine, 2015
- Venous Stenosis After Transvenous Lead Placement: A Study of Outcomes and Risk Factors in 212 Consecutive PatientsJournal of the American Heart Association, 2015
- Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survivalEP Europace, 2014
- Clinical Presentation and Outcomes of Cardiovascular Implantable Electronic Device Infections in Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2014
- Cardiovascular Implantable Electronic Devices in Hemodialysis Patients: Prevalence and Implications for Arteriovenous Hemodialysis Access InterventionsSeminars in Dialysis, 2014
- Variable selection for propensity score models when estimating treatment effects on multiple outcomes: a simulation studyPharmacoepidemiology and Drug Safety, 2012
- End-Stage Renal Disease Predicts Complications in Pacemaker and ICD ImplantsJournal of Cardiovascular Electrophysiology, 2011
- Matching Methods for Causal Inference: A Review and a Look ForwardStatistical Science, 2010
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Variable Selection for Propensity Score ModelsAmerican Journal of Epidemiology, 2006